NCT00851448终止不适用
Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients. A Randomised, Double-blind, Controlled Pilot Study
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 17
- 试验地点
- 3
- 主要终点
- compliance to nutrition therapy
研究概览
简要总结
To test the compliance, tolerance, safety and to get preliminary insights into the efficacy of a new oral nutritional supplement (containing n-3 fatty acids, amino acids and antioxidants) designed to prevent or delay cachexia and anorexia in lung cancer patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •non-small cell lung cancer patients stage IIIb or IV
- •planned chemotherapy or combined chemo-/radiotherapy
- •current body weight less than 6 months ago
- •abnormal CRF level
- •BMI >=20 kg/m2 and <=30kg/m2
排除标准
- •significant oedema in the time of screening and randomisation
- •concomitant inflammatory diseases
- •active infections including HIV and AIDS
- •liver failure
- •chronic renal failure or cardiac pacemaker
- •chronic heart failure
- •insulin treated diabetes mellitus
- •medications that impair sex hormone synthesis, secretion or function
- •acute or chronic infections
- •body weight loss > 5% during the last 6 months or > 10% during the last 10 months
- •fish oil supplementation within 3 months prior to study entry
- •taking vitamins in doses greater than recommended daily allowance
- •life expectancy less than 6 months in the opinion of the investigator
研究组 & 干预措施
1
Experimental
Oral nutritional supplement containing n-3 fatty acids, amino acids, antioxidants
干预措施: oral nutritional supplement, food for special medical purposes (Dietary Supplement)
2
Placebo Comparator
isocaloric, isonitrogenous
干预措施: oral nutritional supplement, food for special medical purposes (Dietary Supplement)
结局指标
主要结局
compliance to nutrition therapy
时间窗: baseline, months 1, 2, 3, 4
次要结局
- ECOG performance status(baseline, months 1, 2, 3, 4)
- anorexia questionnaire(baseline, months 1, 2, 3, 4)
- gastrointestinal syndrome score (GIS)(baseline, months 1, 2, 3, 4)
- body cell mass(baseline, months 1, 2, 3, 4)
- weight change(baseline, months 1, 2, 3, 4)
- hand grip strength(baseline, months 1, 2, 3, 4)
研究者
研究点 (3)
Loading locations...
相似试验
已完成
不适用
Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease PatientsCachexiaChronic Heart FailureChronic Obstructive Pulmonary DiseaseNCT00852020Fresenius Kabi60
已完成
不适用
Effectiveness and Tolerability of an Oral Nutritional Supplement (PreOP Booster) Given Before SurgeryRectal TumorsNCT00730808Fresenius Kabi20
进行中（未招募）
不适用
Evaluation of Four New Ready to Drink Oral Nutritional Supplements: Adult ONS TrialMalnutritionNCT05257980Nutricia UK Ltd100
已完成
不适用
Evaluation of an Oral Nutritional SupplementGastro-intestinal ToleranceNCT01781624Abbott Nutrition25
已完成
1 期
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's DiseaseParkinson DiseaseNCT04685265MODAG GmbH70